Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Protagonist Therapeutics ...

    NASDAQ: PTGX · Real-Time Price · USD
    50.83
    -0.23 (-0.45%)
    At close: Jun 04, 2025, 9:37 AM

    Protagonist Therapeutics Revenue

    Protagonist Therapeutics reported an annual revenue of $434.43M, reflecting a 624.05% growth. For the quarter ending March 31, 2025, Protagonist Therapeutics generated $28.32M in revenue.
    Revenue (ttm)
    $434.43M
    Revenue Growth
    624.05%
    Price / Sales Ratio
    5.47
    Revenue / Employee
    $3.5M
    Employees
    124
    Market Cap
    3.15B

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist